Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CYCC |
---|---|---|
09:32 ET | 1791 | 1.963 |
09:34 ET | 211 | 1.9833 |
09:36 ET | 300 | 1.993 |
09:39 ET | 100 | 1.97 |
09:43 ET | 300 | 1.985 |
09:45 ET | 6800 | 1.942 |
09:50 ET | 22382 | 1.99 |
09:52 ET | 3600 | 2 |
09:57 ET | 200 | 2.03 |
10:01 ET | 479 | 2.015 |
10:06 ET | 1758 | 2.02 |
10:10 ET | 481 | 2 |
10:12 ET | 100 | 2.0399 |
10:14 ET | 611 | 2 |
10:26 ET | 5900 | 1.96 |
10:46 ET | 490 | 1.96 |
10:48 ET | 1600 | 1.9799 |
10:51 ET | 100 | 2 |
10:55 ET | 5923 | 1.95 |
11:00 ET | 7100 | 2.01 |
11:04 ET | 1000 | 2.04 |
11:13 ET | 5900 | 1.97 |
11:15 ET | 580 | 1.95 |
11:18 ET | 1216 | 2.02 |
11:27 ET | 2438 | 2.03 |
11:33 ET | 1200 | 2.03 |
11:36 ET | 800 | 2.05 |
11:40 ET | 7339 | 1.95 |
11:44 ET | 1100 | 2.01 |
12:00 ET | 1200 | 2.025 |
12:07 ET | 5758 | 2 |
12:14 ET | 1310 | 2 |
12:32 ET | 7557 | 1.94 |
12:36 ET | 2200 | 2.0099 |
12:41 ET | 500 | 2.02 |
12:43 ET | 2782 | 1.95 |
12:59 ET | 100 | 1.95 |
01:03 ET | 10079 | 1.92 |
01:06 ET | 3803 | 1.94 |
01:08 ET | 250 | 1.86 |
01:10 ET | 200 | 1.86 |
01:12 ET | 2050 | 1.87 |
01:17 ET | 524 | 1.91 |
01:19 ET | 250 | 1.92 |
01:21 ET | 9700 | 1.92 |
01:24 ET | 1500 | 1.92 |
01:51 ET | 500 | 1.94 |
02:06 ET | 700 | 1.9014 |
02:18 ET | 620 | 1.9 |
02:20 ET | 1600 | 1.87 |
02:22 ET | 732 | 1.87 |
02:27 ET | 300 | 1.8974 |
02:29 ET | 180 | 1.8938 |
02:38 ET | 300 | 1.86 |
02:40 ET | 626 | 1.88 |
03:00 ET | 1100 | 1.89 |
03:09 ET | 140 | 1.9 |
03:12 ET | 300 | 1.8999 |
03:25 ET | 4064 | 1.88 |
03:27 ET | 1300 | 1.87 |
03:30 ET | 500 | 1.87 |
03:43 ET | 100 | 1.87 |
03:48 ET | 1772 | 1.8752 |
03:50 ET | 100 | 1.8799 |
03:57 ET | 500 | 1.88 |
03:59 ET | 283 | 1.88 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cyclacel Pharmaceuticals Inc | 2.9M | -0.1x | --- |
Manuka Inc | 3.4M | -2.4x | --- |
Aditxt Inc | 3.2M | 0.0x | --- |
Regen BioPharma Inc | 3.9M | -4.1x | --- |
Fresh2 Group Ltd | 14.3M | -0.1x | --- |
Lipella Pharmaceuticals Inc | 5.0M | -0.9x | --- |
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin-dependent kinase 9 (CDK9) inhibitor, in solid tumors and hematological malignancies. The epigenetic/anti-mitotic program is evaluating plogosertib, in solid tumors and hematological malignancies. The Company's Plogosertib is a novel, small molecule, selective and potent Polo-like kinase 1 (PLK1) inhibitor, which has demonstrated potent and selective target inhibition (PLK1 IC50 approximately 3 nM) and efficacy in human tumor xenografts at non-toxic doses. Its translational biology program supports the development of plogosertib in solid tumor and hematological malignancy indications.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.9M |
---|---|
Revenue (TTM) | $449.0K |
Shares Outstanding | 1.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.64 |
EPS | $-21.99 |
Book Value | $0.57 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,008.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.